Artículos de revistas
Overcoming Metabolic Syndrome In Severe Obesity: Adiponectin As A Marker Of Insulin Sensitivity And Hdl-cholesterol Improvements After Gastric Bypass [reversão Da Síndrome Metabólica Na Obesidade Mórbida: Adiponectina Como Um Marcador Da Sensibilização à Insulina E Do Aumento Do Hdl-colesterol Após O Bypass Gástrico]
Registro en:
Arquivos Brasileiros De Endocrinologia E Metabologia. , v. 53, n. 2, p. 293 - 300, 2009.
42730
2-s2.0-67649414452
Autor
Geloneze B.
Pereira J.A.
Pareja J.C.
de Oliveira Lima M.M.
Lazarin M.A.C.T.
de Souza I.C.P.
Tambascia M.A.
Chaim E.
Muscelli E.
Institución
Resumen
Objective: To assess the relationship between adiponectin and metabolic parameters in severely obese women during surgical-induced weight loss. Methods: Nineteen lean (CT - BMI:21.2 ± 0.3 kg.m2), 14 overweight/class II obese (OB/OW - BMI: 29.7 ± 0.7 kg/m2) and 8 morbidly obese (OBIII - BMI: 56.4 ± 3.6 kg/m2) were evaluated by hyperinsulinemic-euglycemic clamp, adiponectin, and lipids. OBIII were evaluated at 5th and 16th month post-operatively. Results: Compared to lean, obese groups had lower adiponectin (OB/OW: 9.4 ± 0.9, OBIII: 7.1 ± 1.3 versus 12.2 ± 0.9 ng/dL; p <0.01), lower HDL-cholesterol (OB/OW:1.05 ± 0.05, OBIII: 0.88 ± 0.04 versus 1.22 ± 0.07 mmol/L; p<0.01) and insulin resistance-IR (glucose uptake, M-value - OB/OW: 43.6 ± 2.7, OBIII: 32.4 ± 3.2 versus 20.0 ± 1.8 umol/kgFFM.min; p<0.001). Considering all subjects, adiponectin levels were inversely correlated to BMI and waist circumference, and directly to M-value and HDL-cholesterol (p<0.01). During weight loss, improvements in IR (Study III: 36.1 ± 3.9 umol/kg/FFM.min, p<0.0001), adiponectin (11.8 ± 1.4 ng/dL, p = 0.006) and HDL-cholesterol were observed (1.10 ± 0.04 mmol/L, p = 0.007). Moreover, HDL-cholesterol improvement was significantly and independently related to variations of adiponectin and BMI (r2 = 0.86; p<0.0002). Conclusions: The improvements of IR and adiponectin were related to surgical-induced weight loss, suggesting an important role of adiponectin in HDL-cholesterol regulation. 53 2 293 300 Defronzo, R.A., Ferrannini, E., Insulin resistance: A multifaceted syndrome responsible for niddm, obesity, hypertension, dyslipidemia and atherosclerotic disease (1991) Diabetes Care, 14 (3), pp. 173-194 Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., Mingrone, G., Insulin resistance and hypersecretion in obesity (1997) J Clin Invest, 100 (5), pp. 1166-1173 Definition, diagnosis and classification of diabetes mellitus and its complications (1999), http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf, WHO Consultation, Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, Report no 99.2, Available fromAlberti, K.G., Zimmet, P., Shaw, J., Metabolic syndrome - a new world-wide definition (2006) Diabet Med, 23 (5), pp. 469-480. , A Consensus Statement from the International Diabetes Federation Berg, A.H., Combs, T.P., Scherer, P.E., ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism (2002) Trends Endocrinol Metab, 13 (2), pp. 84-89 Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E., Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia (2001) J Clin Endocrinol Metab, 86 (5), pp. 1930-1935 Szmitko, P.E., Teoh, H., Stewart, D.J., Verma, S., Adiponectin and cardiovascular disease: State of the art? (2007) Am J Physiol Heart Circ Physiol, 292 (4), pp. H1655-H1663 Kazumi, T., Kawagushi, A., Sakai, K., Hirano, T., Yshino, G., Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure (2002) Diabetes Care, 25 (6), pp. 971-976 Pellme, F., Smith, U., Funahashi, T., Matsuzawa, Y., Brekke, H., Wiklund, O., Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients (2003) Diabetes, 52 (5), pp. 1182-1186 Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin (1999) Circulation, 100 (25), pp. 2473-2476 Okamoto, Y., Arita, Y., Nishida, M., Muraguchi, M., Ouchi, N., Takahashi, M., An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls (2000) Horm Metab Res, 32 (2), pp. 47-50 Hotta, K., Funahashi, T., Bodkin, N.L., Ortmeyer, H.K., Arita, Y., Hansen, B.C., Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys (2001) Diabetes, 50 (5), pp. 1126-1133 Lara-Castro, C., Fu, Y., Chung, B.H., Garvey, W.T., Adiponectin and the metabolic syndrome: Mechanisms mediating risk for metabolic and cardiovascular disease (2007) Curr Opin Lipidol, 18 (3), pp. 263-270 von Eynatten, M., Hamann, A., Twardella, D., Nawroth, P.P., Brenner, H., Rothenbacher, D., Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease (2006) Clin Chem, 52 (5), pp. 853-859 Cnop, M., Havel, P.J., Utzschneider, K.M., Carr, D.B., Sinha, M.K., Boyko, E.J., Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex (2003) Diabetologia, 46 (4), pp. 459-469 Baratta, R., Amato, S., Degano, C., Farina, M.G., Patanè, G., Vigneri, R., Adiponectin relationship with lipid metabolism is independent of body fat mass: Evidence from both cross-sectional and intervention studies (2004) J Clin Endocrinol Metab, 89 (6), pp. 2665-2671 Neumeier, M., Sigruener, A., Eggenhofer, E., Weigert, J., Weiss, T.S., Schaeffler, A., High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes (2007) Biochem Biophys Res Commun, 352 (2), pp. 543-548 Vergès, B., Petit, J.M., Duvillard, L., Dautin, G., Florentin, E., Galland, F., Adiponectin is an important determinant of apoA-I catabolism (2006) Arterioscler Thromb Vasc Biol, 26 (6), pp. 1364-1369 Pereira, J.A., Lazarin, M.A., Pareja, J.C., de Souza, A., Muscelli, E., Insulin resistance in nondiabetic morbidly obese patients: Effect of bariatric surgery (2003) Obes Res, 11 (12), pp. 1495-1501 Geloneze, B., Tambascia, M.A., Pareja, J.C., Repetto, E.M., Magna, L.A., The insulin tolerance test in severely obese patients undergoing bariatric surgery (2001) Obes Res, 9 (12), pp. 763-769 de Carvalho, C.P., Marin, D.M., de Souza, A.L., Pareja, J.C., Chaim, E.A., de Barros Mazon, S., GLP-1 and Adiponectin: Effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism (2009) Ob Surg, 19, pp. 313-320 Swarbrick, M.M., Havel, P.J., Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans (2008) Metab Syndr Relat Disord, 6 (2), pp. 87-102 Calvani, M., Scarfone, A., Granato, L., Mora, E.V., Nanni, G., Castagneto, M., Restoration of adiponectin pulsatility in severely obese subjects after weight loss (2004) Diabetes, 53 (4), pp. 939-947 Guldstrand, M., Ahréen, B., Adamsom, U., Improved β-cell function after standardized weight reduction in severely obese subjects (2003) Am J Physiol Endocrinol Metab, 284 (3), pp. E557-E565 Kotidis, E.V., Koliakos, G.G., Baltzopoulos, V.G., Ioannidis, K.N., Yovos, J.G., Papavramidis, S.T., Serum ghrelin, leptin and adiponectin levels before and after weight loss: Comparison of three methods of treatment: A prospective study (2006) Obes Surg, 16 (11), pp. 1425-1432 (1997) Diabetes Care, 20 (7), pp. 1183-1197. , American Diabetes Association, Report of expert Committee on Diagnosis and Classification of Diabetes Mellitus Capella, R.F., Capella, J.F., Reducing early technical complications in gastric bypass surgery (1997) Obes Surg, 7 (2), pp. 149-156 deFronzo, R.A., Tobin, J.D., Andres, R., Glucose clamp technique: A method for quantifying insulin secretion and resistance (1979) Am J Physiol, 237 (3), pp. E214-E223 Geloneze, B., Pareja, J.C., Does bariatric surgery the metabolic syndrome? (2006) Arq Bras Endocrinol Metabol, 50 (2), pp. 400-407 Swarbrick, M.M., Austrheim-Smith, I.T., Stanhope, K.L., van Loan, M.D., Ali, M.R., Wolfe, B.M., Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery (2006) Diabetologia, 49 (11), pp. 2552-2558 Polak, J., Kovacova, Z., Jacek, M., Klimcakova, E., Kovacikova, M., Vitkova, M., An increase in plasma adiponectin multimeric complexes follows hypocaloric diet-induced weight loss in obese and overweight pre-menopausal women (2007) Clin Sci (Lond), 112 (11), pp. 557-565 Yamamoto, Y., Hirose, H., Saito, I., Tomita, M., Taniyama, M., Matsubara, K., Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population (2002) Clin Sci, 103 (2), pp. 137-142 Combs, T.P., Pajvani, U.B., Berg, A.H., Lin, Y., Jelicks, L.A., Laplante, M., A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity (2004) Endocrinology, 145 (1), pp. 367-383 Shibata, R., Ouchi, N., Kihara, S., Sato, K., Funahashi, T., Walsh, K., Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of AMP-activated protein kinase signaling (2004) J Biol Chem, 279 (27), pp. 28670-28674 Westphal, S., Borucki, K., Taneva, E., Makarova, R., Luley, C., Adipokines and treatment with niacin (2006) Metabolism, 55 (10), pp. 1283-1285 Nakamura, T., Kodama, Y., Takano, H., Umetani, K., Fujioka, D., Saito, Y., Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia (2007) Atherosclerosis, 193 (2), pp. 449-451 Hibuse, T., Fujita, K., Nishizawa, H., Adler, Y., Motro, M., Kihara, S., Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level (2007) Arterioscler Thromb Vasc Biol, 27 (3), pp. 635-641 Bahia, L., Aguiar, L.G., Villela, N., Bottino, D., Godoy-Matos, A.F., Geloneze, B., Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in nondiabetic individuals with metabolic syndrome (2007) Atherosclerosis, 195 (1), pp. 138-146 Maruyama, C., Imamura, K., Teramoto, T., Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia (2003) J Atheroscler Thromb, 10 (3), pp. 186-191 Barter, P.J., Puranik, R., Rye, K.A., New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease (2007) Curr Cardiol Rep, 9 (6), pp. 493-498